Riskpilot← Back to searchSign inGet full accessIlliacus AB
ABActiveOrg 5590424312Klintvägen 18Physiotherapy activities · NACE 8695Est. 20151 employees
Revenue 2025
SEK 1,1M
-2% vs 2024
EBITDA margin
3.6%
+8% vs 2024
Equity ratio
46.2%
Financial strength
Net profit 2025
SEK 32K
+7% vs 2024
| Revenue | SEK 1,1M | -2% |
| EBITDA | SEK 40K | +8% |
| Net profit | SEK 32K | +7% |
| Total assets | SEK 192K | -24% |
| Equity | SEK 88K | -35% |
| Employees | 1 | — |
Legal name
Illiacus AB
Org number
5590424312
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
17 december 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva sjukgymnastik, fysioterapi samt därmed förenlig verksamhet, utbildning och föreläsningar, äga och förvalta fastigheter och värdepapper och därmed förenlig verksamhet.
Address
Klintvägen 18
Email
ingvar.palmgren@slgab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 688 | 1 150 | 941 | 1 319 | 1 088 | 1 223 | 1 115 | 1 097 |
| Staff expenses | — | — | — | — | — | — | −653 | −712 | −674 | −661 |
| EBITDA | 95 | 12 | −228 | 117 | 59 | 193 | 1 | 72 | 37 | 40 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — | — |
| EBIT | 95 | 12 | −228 | 117 | 59 | 193 | 1 | 72 | 37 | 40 |
| Net financials | — | — | −1 | −4 | −4 | −52 | −10 | −0 | 1 | 0 |
| Profit before tax | 95 | 12 | −229 | 114 | 55 | 123 | −8 | 54 | 38 | 40 |
| Tax | −22 | −5 | −0 | −0 | −0 | −26 | −0 | −11 | −8 | −9 |
| Net profit | 73 | 7 | −229 | 114 | 55 | 97 | −9 | 43 | 30 | 32 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 169 | 183 | 128 | 153 | 206 | 281 | 160 | 249 | 252 | 192 |
| Equity | 123 | 60 | −169 | −55 | 0 | 97 | 64 | 107 | 137 | 88 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Short-term debt | 46 | 123 | 297 | 209 | 207 | 142 | 54 | 82 | 56 | 43 |
| Total debt | 46 | 123 | 297 | 209 | 207 | 142 | 54 | 82 | 56 | 43 |
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
20162025
Equity ratio
46.2%
This company
38.2%
Market median
+21% vs market
20162025
Return on equity
35.9%
This company
18.4%
Market median
+95% vs market
20162025
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20162025
Asset turnover
5.73×
This company
1.12×
Market median
+412% vs market
20162025
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-12-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PG Audit | Audit | 2020 | — | — |
CH Auditor Substitute | Auditor Substitute | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Illiacus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Göran Eriksson | Audit | 0 companies |
| Carl Håkan Sporrong | Auditor Substitute | 0 companies |
| Ami Karin Marie Palmgren | Deputy Board Member | 0 companies |
| Gösta Ingvar Lennart Palmgren | Board of Directors | 0 companies |